120 related articles for article (PubMed ID: 17384579)
1. A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.
Ng SS; Gao Y; Chau DH; Li GH; Lai LH; Huang PT; Huang CF; Huang JJ; Chen YC; Kung HF; Lin MC
Cancer Gene Ther; 2007 Jun; 14(6):561-72. PubMed ID: 17384579
[TBL] [Abstract][Full Text] [Related]
2. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC
Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
[TBL] [Abstract][Full Text] [Related]
4. Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.
Liu X; Li XP; Peng Y; Ng SS; Yao H; Wang ZF; Wang XM; Kung HF; Lin MC
Chin J Cancer; 2012 Dec; 31(12):588-97. PubMed ID: 23149313
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
6. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
7. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
8. AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.
Harding TC; Lalani AS; Roberts BN; Yendluri S; Luan B; Koprivnikar KE; Gonzalez-Edick M; Huan-Tu G; Musterer R; VanRoey MJ; Ozawa T; LeCouter RA; Deen D; Dickinson PJ; Jooss K
Mol Ther; 2006 May; 13(5):956-66. PubMed ID: 16580881
[TBL] [Abstract][Full Text] [Related]
9. [Effects of double targeting gene therapy by suicide gene combined with endostatin gene in treatment of bladder cancer: an experimental study].
Pan JG; Zhou X; Han RF
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2700-4. PubMed ID: 19080691
[TBL] [Abstract][Full Text] [Related]
10. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
11. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
13. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy.
Hsu PY; Yang YW
J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397
[TBL] [Abstract][Full Text] [Related]
14. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
Ma H; Liu Y; Liu S; Xu R; Zheng D
Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
[TBL] [Abstract][Full Text] [Related]
16. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.
Huo L; Yao H; Wang X; Wong GW; Kung HF; Lin MC
PLoS One; 2010 Sep; 5(9):e12705. PubMed ID: 20856939
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
20. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
